Polymorphs, Salts, and Cocrystals: What’s in a Name?

Aitipamula, Srinivasulu; Banerjee, Rahul; K. Bansal, Arvind; Biradha, Kumar; Cheney, M.L.; Roy Choudhury, Angshuman; R. Desiraju, Gautam; G. Dikundwar, Amol; Dubey, Ritesh; Duggirala, Nagakiran; P. Ghogale, Preetam; Ghosh, Soumyajit; Kumar Goswami, Pramod; Rajesh Goud, N.; R. K. R. Jetti, Ram; Karpiński, Piotr; Kaushik, P.; Kumar, Dinesh; Kumar, Vineet; Moulton, Brian; Mukherjee, Arijit; Mukherjee, Gargi; S. Myerson, Allan; Puri, Vibha; Ramanan, Arunachalam; Thennati, Rajamannar; Malla Reddy, C.; Rodríguez‐Hornedo, Naír; D. Rogers, Robin; N. Guru Row, Tayur; Sanphui, Palash; Shan, Ning; Shete, Ganesh; K. Singh, Amit; Calvin Sun, Changquan; A. Swift, Jennifer; Thaimattam, Ram; S. Thakur, Tejender; Kumar Thaper, Rajesh; P. Thomas, Sajesh; Tothadi, Srinu; Vangala, V.R.; Variankaval, Narayan; Vishweshwar, P.; Weyna, D.R.; J. Zaworotko, Michael

doi:10.1021/cg3002948

Public

Polymorphs, Salts, and Cocrystals: What’s in a Name?

Shared by NobleBlocks on Apr 12, 2012 • 12:00 AM UTC

Authors:

Srinivasulu Aitipamula

Rahul Banerjee

Arvind K. Bansal

Abstract

The December 2011 release of a draft United States Food and Drug Administration (FDA) guidance concerning regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) addressed two matters of topical interest to the crystal engineering and pharmaceutical science...

Subject

Food and drug administration

Session (web analytics)

Crystal engineering

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!